The Role of Molecular Autopsy in Concealed Cardiomyopathies

Oscar Campuzano1,2,3, Coloma Tirón2,3,4,5, Estefanía Martínez-Barrios6,7,8

  • 1Medical Science Department, School of Medicine, University of Girona, 17003 Girona, Spain.

Genes
|November 27, 2025
PubMed

Insights

Early diagnosis of cardiomyopathy is crucial for preventing sudden cardiac death. Incorporating molecular autopsy and family history in forensic protocols aids in identifying occult cardiomyopathies and guiding family risk assessment.

Area of Science:

  • Cardiology
  • Forensic Science
  • Genetics

Background:

  • Early diagnosis of cardiomyopathy is vital for preventing arrhythmias and sudden cardiac death.
  • Sudden death, particularly in young individuals, may be the initial presentation of cardiomyopathy, sometimes without clear structural defects.
  • Autopsies in such cases can be ambiguous, posing challenges for forensic science in identifying occult cardiomyopathies.

Purpose of the Study:

  • To highlight the importance of early and conclusive diagnosis of cardiomyopathy.
  • To address the challenges in diagnosing occult cardiomyopathies in forensic investigations.
  • To emphasize the role of molecular autopsy and family history in improving diagnostic accuracy.

Main Methods:

  • Review of current diagnostic challenges in cardiomyopathy.
  • Discussion of the necessity for enhanced forensic protocols.
  • Integration of molecular autopsy and family history data.

Main Results:

  • Occult cardiomyopathies often remain undiagnosed without specialized testing.
  • Molecular autopsy and comprehensive family history are crucial for suspecting or diagnosing concealed cardiomyopathy.
  • Improved diagnostic approaches can provide answers for unexpected deaths and facilitate family risk assessment.

Conclusions:

  • Enhanced forensic protocols, including molecular autopsy and family history, are essential for identifying occult cardiomyopathies.
  • Accurate diagnosis or suspicion of cardiomyopathy provides closure for families and enables proactive health management for at-risk relatives.
  • Physicians play a key role in initiating family assessments to implement personalized preventive strategies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
483
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
432
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
769